Indomethacin-loaded poly(butylcyanoacrylate) nanoparticles: Preparation and characterization

PDA Journal of Pharmaceutical Science and Technology

Volumn 63, Issue 3, 2009, Pages 207-216

  Liu, Halyan ^a   Chen, Jinchun ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Drug carrier; Indomethacin; Nanoparticles; Polylcyanoacrylate; Polymerization emulsion

Indexed keywords

INDOMETACIN; NANOPARTICLE; POLY(BUTYLCYANOACRYLATE); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; COLLOID; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; PARTICLE SIZE; POLYMERIZATION; X RAY DIFFRACTION;

EMULSIFYING AGENTS; ENBUCRILATE; HYDROGEN-ION CONCENTRATION; INDOMETHACIN; NANOPARTICLES; PARTICLE SIZE; POWDERS; SOLUBILITY; X-RAY DIFFRACTION;

EID: 73449145125     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hubbell, J. A. Materials science. Enhancing drug function. Science 2003, 300 (5619), 595-596.
2. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55 (3), 329-347.
3. Soppimath, K. S.; Aminabhavi, T. M.; Kulkarni, A. R.; Rudzinski, W. E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Controlled Release 2001, 70 (1-2), 1-20. (Pubitemid 32144788)
4. Nair, L. S.; Laurencin, C. T. Biodegradable polymers as biomaterials. Pro Polymer Sci. 2007, 32(8), 762-798.
5. O'Sullivan, C.; Birkinshaw, C. Hydrolysis of poly(n-butyl-cyanoacrylate) nanoparticles using esterase. Polym. Degrad. Stabil. 2002, 78 (1), 7-15.
6. Couvreur, P.; Kante, B.; Roland, M.; Guiot, P.; Bauduin, P.; Speiser, P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 1979, 31(5), 331-332.
7. Couvreur, P.; Vauthier, C. Polyalkylcyanoacrylate nanoparticles as drug carriers: present state and perspectives. J. Controlled Release 1991, 17 (2), 187-198.
8. Lherm, C.; Müller, R. H.; Puisieux, F.; Couvreur, P. Alkylcyanoacrylate drug carriers. II. Cytotoxicity of cyanoacrylate nanoprticles with different alkyl chain length. Int. J. Pharm. 1992, 84 (1), 13-22.
9. Vauthier, C.; Dubernet, C.; Fattal, E.; Pinto-Alphandary, H.; Couvreur, P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 2003, 55 (4), 519-548.
10. Rusu, D.; Cimpoiu, C.; Hodisan, T. The control over the new obtaining procedeum of indomethacin. J. Pharm. Biomed. Anal. 1998, 17(3), 409-413.
11. Stewart, R.; Grosserode, R.; Cheetham, J. K.; Rosenthal, A. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced mitosis during cataract surgery. Clin. Ther. 1999, 21 (4), 723-732.
12. Mentes, J.; Erakgün, T.; Afrashi, F.; Kerci, G. Incidence of cystoids macular edema after uncomplicated phacoemulsification. Ophthalmologica 2003, 217 (6), 408-412. (Pubitemid 37329233)
13. Carless, J. E.; Rowe, J. S. The use of Critical Flicker Fusion frequency test for evaluating some central nervous effects of two indomethacin formulations. J. Pharm. Pharmacol. 1981, 33 (6), 336-337.
14. Eis, M. J.; Watkins, B. M.; Philip, A.; Welling, R. E. Non-steroidal-induced benign structures of colon: a case report and review of the literature. Am. J. Gastroenterol. 1998, 93(1), 120-121.
15. Guterres, S. S.; Weiss, V.; de Lucca Freitas, L.; Pohlmann, A. R. Influence of benzyl benzoate as oil core on the physicochemical properties of spray dried powders from polymeric nanocapsules containing indomethacin. Drug Deliv. 2000, 7 (4), 195-199.
16. Kim, S. Y.; Lee, Y. M.; Kang, J. S. Indomethacin-loaded methoxy poly(ethylene glycol)/poly(D,L-lactide) amphiphilic diblock copolymeric nanospheres: pharmacokinetic and toxicity studies in rodents. J. Biomed. Mater. Res. A 2005, 74 (4), 581-590.
17. Kim, I. S.; Jeong, Y. I.; Cho, C. S.; Kim, S. H. Core-shell type polymeric nanoparticles composed of poly(L-lactic acid) and poly(N- isopropylacrylamide). Int. J. Pharm. 2000, 211(1-2), 1-8.
18. Longuemard, P.; Jbilou, M.; Guyot-Hermann, A.-M.; Guyot, J.-C. Ground and native crystals: comparison of compression capacity and dissolution rate. Int. J. Pharm. 1998, 170 (1), 51-61.
19. Ponchel, G.; Montisci, M.-J.; Dembri, A.; Durrer, C.; Duchêne, D. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract: bioadhesion: state-of-the-art and perspectives. Eur. J. Pharm. Biopharm. 1997, 44 (1), 25-31.
20. Xia, H. S.; Wang, Q. Synthesis and characterization of conductive polyaniline nanoparticles through ultrasonic assisted inverse microemulsion polymerization. J. Nanopart. Res. 2001, 3 (5-6), 399-409.
21. Fawaz, F.; Guyot, M.; Lagueny, A. M.; Devissaguet, J. P. Ciprofloxacin-loaded polyisobutyl-cyanoacrylate nanoparticles: preparation and characterization. Int. J. Pharm. 1997, 154 (2), 191-203.
22. Gupta, A. K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26 (18), 3995-4021. (Pubitemid 40044762)
23. Chouinard, F.; Buczkowski, S.; Lenaerts, V. Poly(alkylcyanoacrylate) nanocapsules: physicochemical characterization and mechanism of formation. Pharm. Res. 1994, 11 (6), 869-874.
24. Prot, O.; Benoit, E.; Maincent, P.; Bessiere, J. Adsorption of beta-blockers onto poly(isobutylcyanoacrylate) nanoparticles: adsorption model and dielectric interpretation. J. Colloid. Interface Sci. 1996, 184 (1), 251-258.
25. Brasseur, N.; Brault, D.; Couvreur, P. Adsorption of hematoporphyrin onto polyalkylcyanoacrylate nanoparticles: carrier capacity and drug release. Int. J. Pharm. 1991, 70 (1-2), 129-135.
26. Davis, S. S.; Ilium, L.; McVie, J. G.; Tomlinson, E. Microsphere and Drug Therapy, 1st ed.; Elsevier Science Publishers: New York, 1984; p 103.
27. Douglas S. J.; Ilium, L.; Davis, S. S.; Kreuter, J. Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers. J. Colloid. Interface Sci. 1985, 103 (1), 154-163.
28. Douglas S. J.; Davis S. S. Molecular weights of poly (butyl 2-cyanoacrylate) produced during nanoparticle formation. Br. Polymer J. 1985, 17 (4), 339-342.
29. Kreuter, J. Colloidal Drug Delivery Systems; Marcel Dekker Inc.: New York, 1994; Vol.66, p 219.
30. Mitra, A.; Lin, S. J. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems. J. Pharm. Pharmacol. 2003, 55 (7), 895-902.
31. Feng, S. S.; Huang, G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. J. Controlled Release 2001, 71 (1), 53-69. (Pubitemid 32195441)
32. Van Snick, K.; Couvreur, P.; Christiaens-Leyh, D.; Roland, M. Molecular weights of free and drug-loaded nanoparticles. Pharm. Res. 1985, 2 (1), 36-41.
33. Arias, J. L.; Gallardo, V.; Ruiz, M. A.; Delgado, A. V. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres. Int. J. Pharm. 2007, 337 (1-2), 282-290.
34. Lenaerts, V.; Couvreur, P.; Christiaens-Leyh, D.; Joiris, E.; Roland, M.; Rollman, B.; Speiser, P. Degradation of poly(isobutyl cyanoacrylate) nanoparticles. Biomaterials 1984, 5(2), 65-68.
35. Huang, C.-Y.; Lee, Y.-D. Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation. Int. J. Pharm. 2006, 325(1-2), 132-139.